HealthStream 2026 Q3 Earnings Call
Review the key takeaways and the transcript of this earnings call.
- Third-quarter revenue was $83.3 million, up 8.9% year over year; adjusted EBITDA was $19.3 million, up 1%, with a 23.2% margin.
- Operating income was $6.6 million, down 13%; net income was $5.4 million, down 11.7%; EPS was $0.18 per share, compared with $0.20 per share in the prior-year quarter.
- Subscription revenue increased by $6.2 million, or 8%, and professional services revenue increased by $0.7 million, or 26.2%. Organic revenue growth was 4.7% and inorganic revenue growth was 4.2%.
- CredentialStream grew by 15%, ShiftWizard by 20%, resuscitation suite by 14%, the competency family of products by 10%, and my clinical exchange by 34%.
- Revenue for the first nine months of the year was $248.2 million, up 10.6%; adjusted EBITDA was $60 million, up 13.4%.
- Cash and marketable securities totaled $115.2 million at quarter-end, with no debt. The company raised approximately $40 million through a private placement of common stock at $2,950 per share and extended its $50 million line of credit facility.
- Year-to-date cash flows from operations were $58 million, up 16%, and free cash flow was $34.7 million, up 40%. The company spent $7.4 million on capital expenditures and returned $1 million to shareholders through dividends during the quarter.
- Remaining performance obligations were $686 million at quarter-end, compared with $621 million in the prior-year period; approximately 41% is expected to convert to revenue over the next 12 months and 68% over the next 24 months.
- Legacy and sunsetting products generated approximately $8.7 million, or roughly 10% of third-quarter revenue, and declined by $1.5 million, or 15%, year over year.
- My clinical exchange revenue increased 26.5% year over year. At quarter-end, it had more than 219,000 unique student users across more than 2,100 academic sites and had placed more than 564,000 clinical rotations.
- Across 79 G2 reports in which HealthStream products were ranked this fall, the company placed in the top three in 26 reports, including first place in 15, and received 30 badges, including 18 leader badges. Its average rating rose to 4.5 stars, and its reviewer net promoter score increased from 36 to 69.
STOCKNOW INSIGHTS
Continue with outlook and guidance.
Log in to unlock executive comments and Q&A highlights.
Log in for the full summaryStockNow uses AI to translate and summarize earnings calls. Accuracy and completeness are not guaranteed.
Transcript
Preview the first fifteen paragraphs, organized by speaker.
Good morning, and welcome to HealthStream's third quarter 2026 earnings conference call. At this time, I would like to inform you that this conference is being recorded and that all participants are in a listen-only mode. At the request of the company, we will open the conference up for questions and answers after the presentation. I will now turn the conference over to Mollie Condra, Head of Investor Relations and Corporate Communications. Please go ahead, Ms. Condra.
Thank you, and good morning. Thank you for joining us today to discuss our third quarter 2026 results. Also on the conference call with me is Robert A. Frist Jr., CEO and Chairman of HealthStream, and Scotty Roberts, CFO and Senior Vice President of Finance and Accounting. I would also like to remind you this morning that this conference call may contain forward-looking statements regarding future events and the future performance of HealthStream that involve risk and uncertainties that could cause the actual results to differ materially from those projected in the forward-looking statements. Information concerning these risks and other factors that could cause the results to differ materially from those forward-looking statements are contained in the company's filings with the SEC, which including Forms 10-K, 10-Q, and our earnings release.
Additionally, we may reference certain non-GAAP financial measures relating to the company's past and future expected performance on this call. The most directly comparable GAAP financial metrics and reconciliations are included in the earnings release that we issued yesterday. With that start, I'll now turn the call over to CEO Bobby Frist.
Good morning, everyone. Welcome to our third quarter 2026 earnings call. We do have a lot to cover, so let's get started with the numbers. It was another solid quarter, which is allowing us to raise our previous guidance for the second quarter in a row. For updated full-year guidance, we now expect revenues of $331 million-$333 million, net income of $21.8 million-$22.4 million, and adjusted EBITDA of $77 million-$78 million, each representing an improvement over the ranges we shared with you in August. Revenues in the quarter for the third quarter were $83.3 million, up 8.9% year-over-year, and adjusted EBITDA was $19.3 million, representing a margin of 23.2%. That means revenue came in a little above the midpoint that we were forecasting in August, and EBITDA margin also outperformed the 22% we had been forecasting.
For the first 9 months of the year, revenues were up 10.6% to $248.2 million, and adjusted EBITDA was up 13.4% to $60 million. Importantly, and this is kind of the color around it, we achieved these results while investing more aggressively in the future growth drivers, including our hStream platform technology, our career networks, which we talked about in the last call, and also importantly, our sales organization as we get ready for our sales kickoff meeting in early January of next year. Those investments are reflected in our operating expenses this quarter, and we believe they are laying the foundation for the next chapter of HealthStream's growth. We also took the time to strengthen our balance sheet in the quarter. in September, we received approximately $40 million in cash proceeds through a private placement of HealthStream common stock at $29.50 per share.
We view this investment as a meaningful endorsement of our strategy and the long-term value of HealthStream ecosystem. Therefore, we ended the quarter with $115.2 million in cash and marketable securities and no debt, which puts us in a strong position to continue investing in our solutions and platform, pursue acquisitions that expand our ecosystem, and create lasting value for shareholders. With an untapped line of credit in addition to our cash, we have the flexibility to act quickly when the right M&A opportunities arrive, and we do plan on having an active pipeline. We're always on the look for good opportunities while continuing to pursue other capital deployment strategies that we believe will benefit shareholders across the board. Advances in our hStream technology platform are allowing us to deploy more complete solutions that address the totality of a healthcare organization's competency, compliance, and development needs.
More specifically, the single verified clinician record, which is at the heart of the hStream technology platform, is enabling robust programmatic solutions that replace the disparate point solutions of the past. We call these programmatic solutions suites, and the key examples include our Competency Suite, our Compliance Suite, and our Resuscitation Suite. These suites are built to drive enterprise-level outcomes. They engage individual caregivers at a personalized level while also enabling organizations clear, actionable, and efficient ways to run and improve their operations. The sales momentum and customer feedback regarding these suites lets us know that we are onto something meaningful here. I know we talked a good bit about AI last time. I want to repeat some of the fundamentals of AI as it relates to our vision, philosophy, and direction. It continues to be an important part of our vision.
On recent calls, I've shared four reasons we believe HealthStream is well-positioned as AI reshapes healthcare technology, and our conviction in each of these four areas has only grown since the last call. First, I point out that our user base is growing. While some industries may see AI reduce the number of software seats they need, healthcare employment is projected to remain one of the strongest engines of job growth, and nurses specifically, who make up our largest group of users, are at the heart of that growth. We see AI as a tool that will free caregivers from administrative tasks so they can devote more time to their patients, which is a great thing overall for all of us that could be patients.
Second, our data sets us apart. I think it would be extraordinarily difficult to replicate and assemble the unique data sets that we have accumulated over time. Millions of healthcare professionals, for example, have a unique HealthStream ID issued by our platform as they operate in our platform. Our enterprise applications serve as systems of record for how healthcare organizations train, credential, and schedule their workforce. This is important. Our new career networks add proprietary insight into how clinicians learn, work, and build their careers. For example, NurseGrid alone reaches roughly 1 in 5 U.S. nurses. That depth and history give us a foundation for AI that would be very difficult for newer entrants to match. Third, HealthStream, our platform, was built with AI as a core capability.
Foundational assets like HealthStream ID and our growing set of APIs gives us the infrastructure to support AI-driven innovation in the healthcare workforce technology. Our developer portal, for example, now has 890 registered users across 441 customers who are already building dozens of integrations through our APIs. Fourth, our ecosystem ties these strengths together. Thousands of healthcare organizations, millions of caregivers, dozens and dozens of industry partners, and more than three decades of healthcare expertise form a platform that would be very difficult to replicate. AI cannot build an ecosystem like ours, but we believe it can make ours even more valuable. Taken together, these advantages are why we believe HealthStream is uniquely positioned as AI reshapes healthcare. The more clinicians, data, and solutions we connect to our platform, the more valuable each of those advantages becomes.
Before I go further, I want to briefly summarize HealthStream for anyone who is new to our story, and we hope there are lots of new people to our story today. HealthStream is a healthcare technology platform company, and we are focused exclusively on the clinical workforce. Through our HealthStream platform, we deliver the healthcare industry's largest ecosystem of clinical workforce solutions, helping organizations find, develop, credential, schedule, engage, and retain their people, with each solution becoming more valuable as it connects to the other solutions. Our reach extends from nursing students preparing for their first clinical rotation to experienced clinicians, and the 13.7 million healthcare professionals and nursing students in the United States make up the core addressable market for our solutions. Our innovation is backed by 24 patents and more than 40 Brandon Hall awards. Our business model is built for durability.
96% of our revenues are subscription-based under contracts that typically run three to five years, which makes our revenue highly recurring and predictable. We are profitable with no debt and a strong balance sheet, and those things give us the flexibility to invest more in our platform, pursue acquisitions, and return capital to shareholders. Later in the call, I will share more about the momentum we are seeing with our customers and the progress we are making across our solutions and platform. First, let us turn our attention to a more detailed look at the numbers with Scotty Roberts, our CFO, and he will look at some financial metrics for the third quarter, along with further comments about our financial outlook for 2026. Scotty, it is yours. Okay.
Thanks, Bobby, and good morning to everyone who is joining the call with us today. During the third quarter, we delivered solid financial performance while also strengthening our balance sheet by raising $40 million in cash through the issuance of our common stock in a private placement transaction. We also extended our $50 million line of credit facility, providing additional access to capital. With cash and investment balances of over $115 million, access to a $50 million credit facility, positive free cash flow, and no funded debt, we are well-positioned to grow the business and improve shareholder value. Now let's go over the financial results for the third quarter. Revenues were $83.3 million and were up 8.9%. Operating income was $6.6 million, down 13%. Net income was $5.4 million, down 11.7%. EPS was $0.18 per share, down from $0.20 per share.
Adjusted EBITDA was $19.3 million and was up 1%. Our revenues increased by $6.8 million, or 8.9%, and were $83.3 million compared to $76.5 million in the prior year. Revenues from subscription products increased by $6.2 million, or 8%, and professional service revenues increased by $0.7 million, or 26.2%. Our subscription solutions continued to deliver solid growth with an organic revenue growth rate of 4.7%, which was led by products like CredentialStream growing by 15%, ShiftWizard growing by 20%, Resuscitation Suite growing by 14%, the Competency family of products growing by 10%, and myClinicalExchange growing by 34%. Our inorganic revenue growth rate was 4.2%, which is comprised of $3.2 million in revenues from the Virsys12 and MissionCare Collective acquisitions that we completed in the fourth quarter of 2025. As a reminder, our legacy products include acquired credentialing and scheduling products such as EchoCredentialing and ANSOS.
We do not sell legacy products to new customers, though we continue to support, maintain, and renew legacy products for existing customers of those products. However, when a product moves to the sunsetting stage, we no longer sell or renew that product, and it's on a clear lifecycle run-out path. Examples of sunsetting products include things like discontinued partner products that were driven by a mandated regulatory deadline, which has passed, and acquired products that we sunset in favor of newer solutions. We plan to continue actively managing legacy products, but over time, we may transition those into sunsetting products as we focus on newer solutions. Revenues from our legacy and sunsetting products approximated $8.7 million, or roughly 10% of third quarter revenues, and declined by $1.5 million, or 15%, compared to the third quarter of last year.
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Log in to unlock every statement, the English original, and speaker-by-speaker history.
Log in for the full transcriptCall participants
10 people spoke on this call — only 2 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring
